NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/arden ...

New York, New York--(Newsfile Corp. - January 21, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

LOS ANGELES, Jan. 20, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CLICK HERE BEFORE MARCH 9, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About? The complaint filed alleges that, betwe ...

Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. following its poor Q3 2025 financial results, alleging misleading statements regarding revenue recognition and liability reserves [1][2]. Group 1: Allegations and Lawsuit Details - Hagens Berman is investigating claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves [2]. - The lawsuit claims that Ardent assured investors of an active monitoring process for accounts receivable, which was misleading as the company primarily used a 180-day cliff for reserving accounts [4][6]. - The truth emerged on November 12, 2025, when Ardent disclosed a new accounting method that resulted in a revenue reduction of $42.6 million due to hindsight evaluations [5][6]. Group 2: Financial Impact and Market Reaction - Following the earnings call, Ardent's CFO revealed that the company's collectability framework utilized a 180-day cliff for reserving accounts, contradicting previous assurances [6]. - The company also reported an increase in total operating expenses as a percentage of total revenue, driven by a $47.2 million increase in professional liability reserves [6]. - The market reacted negatively, with Ardent's share price dropping by $4.75, or 33%, the day after the announcement [6]. Group 3: Investor Actions and Whistleblower Information - Investors who purchased Ardent securities between July 18, 2024, and November 12, 2025, and suffered losses are encouraged to contact Hagens Berman [2][4]. - Whistleblowers with non-public information regarding Ardent Health are urged to consider their options to assist in the investigation, with potential rewards under the SEC Whistleblower program [7].

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for misrepresentations regarding its accounts receivable during the Class Period from July 18, 2024, to November 12, 2025, potentially affecting investors who purchased securities during this time [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that Ardent Health made false statements about its accounts receivable management, claiming it used detailed reviews of historical collections and monitored collectability, which was not the case [5]. - Defendants reportedly downplayed increased claim denials by third-party payors, misrepresenting the nature of these denials and failing to write off uncollectible accounts [5]. - The firm did not maintain sufficient professional malpractice liability insurance, contrary to its claims, leading to potential investor damages when the truth was revealed [5]. Group 2: Investor Information - Investors who purchased Ardent Health securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff is needed to represent the class, and interested parties must move the Court by March 9, 2026 [1][3].

Company Overview - Ardent Health, Inc. is a Nashville-based hospital operator focused on acute care, managing 30 hospitals across six states through a mix of wholly owned and joint venture structures, with the majority of its operations tied to joint ventures where Ardent retains control and economic ownership [2] - The company generates revenue primarily through traditional reimbursement channels such as Medicare, Medicaid, and commercial insurers, with Medicare and private payors making up the majority of its revenue mix, while Medicaid represents only about 10%, limiting exposure to government reimbursement volatility [2] Business Model - A defining feature of Ardent's model is that it does not own its hospital real estate, instead leasing facilities under a long-term triple-net master lease with Ventas that runs through 2035 and carries manageable covenant requirements [3] - The company's modern structure was shaped by Equity Group Investments' acquisition in 2015, which doubled hospital count and revenue by 2020, followed by a $500 million strategic investment from Pure Health in 2022 and an IPO in July 2024 [3] Financial Performance - As of January 13th, Ardent's share was trading at $8.84, with trailing and forward P/E ratios of 5.97 and 5.36 respectively [1] - Ardent remains well-capitalized with $609 million in cash, a favorable debt maturity profile extending largely beyond 2029, and LTM EBITDA of approximately $478 million, implying a 6x EV/EBITDA multiple [4] - Despite facing temporary issues in the third quarter, including elevated payor denials and a one-time change in revenue cycle accounting, admissions and revenue trends remain solid, indicating potential for modest EBITDA growth and a mispricing of the stock relative to normalized earnings power [4] Market Context - Since going public, Ardent's shares have declined roughly 50%, driven by temporary operational challenges, but the fundamentals of the business remain intact [3][4] - The bullish thesis on Ardent Health emphasizes its joint venture model, leased real estate, and disciplined capital allocation, drawing parallels to the successful operational strategies of Tenet Healthcare Corporation [5]

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allegedly allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter due to "hindsight evaluations of historical collection trends" [5]. - Additionally, the company increased its professional liability reserves by $54 million due to adverse prior period claim developments [5]. - Following this announcement, Ardent Health's stock price fell by $4.75 per share, a decline of over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to lead the case, with claims asserted under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. due to allegations of violations of federal securities laws related to misleading statements about the company's accounts receivable and professional malpractice liability insurance [2][5]. Group 1: Legal Investigation and Class Action - The firm is encouraging investors who suffered losses in Ardent between July 18, 2024, and November 12, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Ardent, with a deadline of March 9, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that Ardent and its executives made false statements and failed to disclose critical information regarding the company's financials [5]. Group 2: Financial Impact and Stock Performance - On November 12, 2025, Ardent announced a $43 million reduction in revenue due to accounting changes and a $54 million increase in professional liability reserves [5]. - Following this announcement, Ardent's stock price fell by $4.75 per share, or 33.81%, closing at $9.30 per share on November 13, 2025 [6]. Group 3: Firm Background and Contact Information - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Ardent's conduct [8].